CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 653079-653183 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T94677","span":{"begin":0,"end":104},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In contrast, treatment options for patients with NSCLC and EGFR wild-type (wt), VS-P status are limited."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T90","span":{"begin":0,"end":104},"obj":"Sentence"}],"text":"In contrast, treatment options for patients with NSCLC and EGFR wild-type (wt), VS-P status are limited."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T1369","span":{"begin":49,"end":54},"obj":"Phenotype"}],"attributes":[{"id":"A1369","pred":"hp_id","subj":"T1369","obj":"http://purl.obolibrary.org/obo/HP_0030358"}],"text":"In contrast, treatment options for patients with NSCLC and EGFR wild-type (wt), VS-P status are limited."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3109","span":{"begin":49,"end":54},"obj":"Disease"},{"id":"T90954","span":{"begin":49,"end":54},"obj":"Disease"}],"attributes":[{"id":"A3109","pred":"mondo_id","subj":"T3109","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"id":"A63512","pred":"mondo_id","subj":"T90954","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"}],"text":"In contrast, treatment options for patients with NSCLC and EGFR wild-type (wt), VS-P status are limited."}